D3 Bio’s $62 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati represented the investors in the transaction.D3 Bio, Inc, a clinical-stage biotechnology announced its closing of a $62 million Series A financing round….

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here